Guselkumab for Crohn's disease: the IL-23 blockade revolution. Dziegielewski C, Singh S. Lancet 2025 Jul 17:S0140-6736(25)00874-8. doi: 10.1016/S0140-6736(25)00874.

Read + Share

Amedeo Smart

Independent Medical Education

Dziegielewski C, Singh S. Guselkumab for Crohn's disease: the IL-23 blockade revolution. Lancet 2025 Jul 17:S0140-6736(25)00874-8. doi: 10.1016/S0140-6736(25)00874.
PMID: 40684777